November 1, 2009
By:Peter O'Donnell
Health concerns require EU regulators to become more involved in the politics of health care.
 |
October 1, 2009
By:Peter O'Donnell
The EU struggles to get over its regulatory hurdles in an effort to further R&D success.
|
September 1, 2009
By:Peter O'Donnell
The globalization of clinical research leads both sides of the Atlantic to collaborate on GCP inspections.
|
August 1, 2009
By:Peter O'Donnell
Contradicting decisions call for a unified clinical trial authorization process.
|
July 1, 2009
By:Peter O'Donnell
European Union health ministers begin reviewing proposals to better adverse event assessment in Europe.
|
June 1, 2009
By:Peter O'Donnell
EMEA releases new guideline for studies in PTSD, as new figures depict a lagging EU.
|
May 1, 2009
By:Peter O'Donnell
Changing rules on advanced therapy medicinal products to require more from clinical studies.
|
April 1, 2009
By:Peter O'Donnell
As EU debates plans for advancing R&D in rare diseases, industry assesses the risks and benefits.
|
March 1, 2009
By:Peter O'Donnell
Ten-year-old study sets precedent for future collaborative observational studies on drug safety.
|
| 
